Related by context. Frequent words. (Click for all words.) 83 Cholesterol Drug 78 Cholesterol Drugs 78 Diet Pill 77 Blood Thinner 77 FDA Accepts 77 Generic Version 77 Patient Enrollment 77 Cervical Cancer Vaccine 75 Improves Survival 75 Drug Candidate 74 Smallpox Vaccine 74 Phase III Clinical Trial 73 Flu Vaccines 73 Drug Makers 73 Receives Orphan Drug Designation 73 Prostate Cancer Patients 72 Clinical Trial Results 72 Cold Medicines 72 Hormone Therapy 72 Pulmonary Arterial Hypertension 72 Bird Flu Vaccine 72 Single Dose 72 Anthrax Vaccine 71 Positive Opinion 71 Completes Enrollment 71 FDA Clears 70 Phase III Trial 70 Diabetic Patients 70 Pivotal Phase III 70 Pivotal Trial 70 Develop Novel 69 Tumor Growth 69 Breast Cancer Treatment 69 Pivotal Phase 69 Prostate Cancer Treatment 69 Preclinical Data 69 Advanced Prostate Cancer 69 Lung Cancer Patients 69 Reduces Risk 69 FDA Warns 69 Well Tolerated 69 Pivotal Study 69 Recombinant Human 69 Medication Errors 69 Malaria Vaccine 69 Low Dose 69 Kidney Failure 68 Initiate Phase 68 Swine Flu Vaccine 68 Presents Positive 68 Extended Release 68 FY# Guidance 68 FDA Clearance 68 Overactive Bladder 68 Initiates Phase II 68 Chronic Hepatitis B 68 FDA Approval 68 Venous Thromboembolism 68 Cancer Treatments 68 Significantly Reduces 68 Influenza Vaccine 68 Cholesterol Levels 68 Announces FDA Clearance 67 FDA Approves 67 Pediatric Patients 67 Antipsychotic 67 II Clinical Trial 67 Heart Failure Patients 67 Anti Inflammatory 67 RNAi Therapeutics 67 Generic Drug 67 Patent Lawsuit 67 H#N# Vaccines 67 Stock Buyback 67 Drug Resistant 67 Patients Undergoing 67 Significantly Improves 67 Autoimmune Disease 67 Stomach Cancer 66 Billion Share Repurchase 66 Gum Disease 66 Study Demonstrates 66 Elderly Patients 66 Patent Covering 66 Allergic Rhinitis 66 Issues Guidance 66 Renal Cell Carcinoma 66 Drop Sharply 66 Increases Risk 66 Jobless Benefits 66 Quitting Smoking 66 Chronic Hepatitis C 66 Warning Labels 66 Patient Outcomes 65 Benign Prostatic Hyperplasia 65 Receives FDA Clearance 65 Vitamin D Deficiency 65 Cardiovascular Events 65 Monotherapy 65 Postmenopausal Women 65 Aliskiren